, ,

An accomplished medical professional with a long resume of achievements on the clinical and research fronts, Dr. Gustavo Stringel currently applies his skills as Surgeon in Chief and Director of Pediatric Surgery and Minimally Invasive Surgery at Westchester Medical Center’s Maria Fareri Children’s Hospital (MFCH). Maintaining his leadership role at the Valhalla, New York-based healthcare facility since 1994, Dr. Stringel has implemented a wide array of general efficiency and inter-departmental improvements, endeavors specifically designed to increase the hospital’s already high standards of care. In conjunction with his daily responsibilities supervising operating room and surgical services activities, Dr. Gustavo Stringel spearheaded the recruitment of extensively trained physicians who specialize in cardiac surgery, neurosurgery, liver transplantation, plastic surgery, anesthesiology, and numerous other pediatric subspecialties. Dr. Stringel also played a key role in developing the hospital’s Division of Minimally Invasive Surgery, leveraging his ties in the local and national medical communities to negotiate the purchase of cutting-edge Storz OR 1, laparoscopic, and robotic daVinci Surgical System equipment.

Additionally functioning as Chairman of the Maria Fareri Children’s Hospital Surgical Services Committee, Dr. Gustavo Stringel devotes a considerable amount of time and energy toward ensuring the treatment center’s continued expansion and long-term success. A world-class pediatric hospital that houses an extremely sophisticated Level IV Neonatal Intensive Care Unit (NICU), the facility further boasts distinction as the only Pediatric Organ Transplant Center in the region. MFCH continues to flourish under Dr. Stringel’s deft supervision, offering state-of-the-art, compassionate care to more than 20,000 boys and girls on an annual basis. Thanks to the impressive efforts put forth by Dr. Stringel and his colleagues, the hospital earned coveted sponsorship backing from the American Lung Association (ALA), funds allocated directly to the Pediatric Asthma Clinical Research Center, one of only five in the entire United States.